The popularity of Sildenafil initially drove a surge for the drug industry, however recent developments present a uncertain outlook for investors. Off-patent versions are reducing earnings, and continued litigation add https://murraywebs495461.livebloggs.com/47946330/sildenafil-and-big-pharma-a-risky-play